Number of the records: 1  

adalimumab

  1. Record numberd000068879
    Date06.06.2025
    TypeM
    Topical termadalimumab
    Other termSlovak (Pseudonym) protilátka D2E7
    Slovak (Pseudonym) adalimumab-adbm
    Slovak (Pseudonym) adalimumab-atto
    Slovak (Pseudonym) Amjevita
    Slovak (Pseudonym) Cyltezo
    Slovak (Pseudonym) Humira
    See also(Later heading) faktor nekrotizujúci nádory, alfa
    (Skutočné meno) antireumatiká
    (Skutočné meno) inhibítory faktora nekrotizujúceho nádory
    (Skutočné meno) faktor nekrotizujúci nádory, alfa
    UDCD12.776.124.486.485.114.224.060.250D12.776.124.790.651.114.224.060.250D12.776.377.715.548.114.224.200.250
    NoteA humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all